跳至主要内容
临床试验/NCT03476811
NCT03476811已完成2 期

Postoperative subQ Pain Control for Spinal Fusion Surgery

University of Arizona1 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2018年2月9日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
11
试验地点
1
主要终点
Pain control

研究概览

简要总结

Post-operative pain following lumbar spine fusion is frequently difficult to manage and can lead to increased doses of opiate pain medications to control pain. In this study, the use of subcutaneous local anesthesia will be studied to determine its efficacy at reducing post-operative pain following spinal fusion surgery.

详细描述

For patients randomized to the experimental or to the placebo groups, two subcutaneous catheters will be tunneled under the skin with large hollow-bore needles along the entire length of the incision on either side prior to closure. These catheters will deliver study drug (0.25% Marcaine) directly into the incision. They will be affixed to the skin with steri-strips. The catheters will then be attached to a drug delivery pump at 2mL/hour and will be removed prior to discharge.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient 18 years of age or greater
  • Surgery to be done at Banner University Medical Center-Tucson
  • Elective Surgeries only
  • Lower Thoracic or Lumbar fusions only - Posterior Approach
  • Postero or Posterolateral Instrumented Fusions with or without Interbody graft
  • Transforaminal Interbody Fusions
  • Must be able to cooperate in the daily VAS assessment

排除标准

  • Patients under 18 years of age
  • Prisoners
  • Pregnant women
  • Hypersensitivity to infusion medication
  • Deformity Correction cases requiring osteotomies
  • Surgical fusion in acute phase for traumatic injury
  • Anterior Lumbar Interbody Fusion, Direct Lateral Interbody Fusion procedures

研究组 & 干预措施

Marciano Group

Active Comparator

Subcutaneous pain control with OnQ pump (0.25% Marcaine at 2ml/hr) and pain medications.

干预措施: 0.25% Marcaine at 2ml/hr and pain medications (Drug)

Placebo Group

Placebo Comparator

OnQ pump with placebo (normal saline at 2ml/hr) and pain medications.

干预措施: Placement of OnQ Drug pump (Device)

结局指标

主要结局

Pain control

时间窗: From post operative day 1 until patient discharge or 30 days, whichever comes first

A daily Visual Analog Score Pain scale (1-10) for pain severity, (1 least pain, 10 most pain) will be assessed and recorded daily by a blinded assessor.

次要结局

  • Time to discharge(from the day of hospital admission to the day of hospital discharge or 45 days, whichever comes first.)
  • Total Milligrams of IV pain medication(from the first post-operative dose of IV pain medication until the last dose prior to discharge from the hospital or 45 days, whichever comes first)
  • Total Doses of IV pain medication(from the first post-operative dose of IV pain medication until the last dose prior to discharge from the hospital or 45 days, whichever comes first)
  • Total Milligrams of oral pain medication(from the first post-operative dose of oral pain medication until the last dose prior to discharge from the hospital or 45 days, whichever comes first)
  • Total Doses of oral pain medication(from the first post-operative dose of oral pain medication until the last dose prior to discharge from the hospital or 45 days, whichever comes first)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert Bina

Neurosurgery Resident

University of Arizona

研究点 (1)

Loading locations...

相似试验

Postoperative subQ Pain Control for Spinal Fusion... | 临床试验